Safeguard Scientifics (NYSE: SFE) is one of 53 publicly-traded companies in the “Investment Management & Fund Operators” industry, but how does it compare to its competitors? We will compare Safeguard Scientifics to related companies based on the strength of its profitability, institutional ownership, risk, analyst recommendations, dividends, valuation and earnings.
Risk & Volatility
Safeguard Scientifics has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, Safeguard Scientifics’ competitors have a beta of 1.23, meaning that their average stock price is 23% more volatile than the S&P 500.
Institutional and Insider Ownership
77.6% of Safeguard Scientifics shares are held by institutional investors. Comparatively, 62.1% of shares of all “Investment Management & Fund Operators” companies are held by institutional investors. 2.7% of Safeguard Scientifics shares are held by insiders. Comparatively, 10.4% of shares of all “Investment Management & Fund Operators” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Earnings & Valuation
This table compares Safeguard Scientifics and its competitors revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Safeguard Scientifics||N/A||-$17.72 million||-2.73|
|Safeguard Scientifics Competitors||$3.00 billion||$962.04 million||6.49|
Safeguard Scientifics’ competitors have higher revenue and earnings than Safeguard Scientifics. Safeguard Scientifics is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of current ratings and target prices for Safeguard Scientifics and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Safeguard Scientifics Competitors||357||1772||1791||62||2.39|
As a group, “Investment Management & Fund Operators” companies have a potential upside of 5.89%. Given Safeguard Scientifics’ competitors higher probable upside, analysts clearly believe Safeguard Scientifics has less favorable growth aspects than its competitors.
This table compares Safeguard Scientifics and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Safeguard Scientifics Competitors||-46.95%||10.51%||5.73%|
Safeguard Scientifics competitors beat Safeguard Scientifics on 6 of the 9 factors compared.
About Safeguard Scientifics
Safeguard Scientifics, Inc. is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies. The Company offers operational and management support to each of its partner companies. In addition to management and operational support, the Company offers ongoing planning and development assessment. It provides mentoring, advice and guidance to develop partner company management. The Company serves on the boards of directors of its partner companies, working with them to develop and implement strategic and operating plans. It measures and monitors achievement of these plans through regular review of operational and financial performance measurements.
Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.